Investor Relations

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Jun 30, 2023

Company Overview

Benitec Biopharma Inc. is a development-stage biotechnology company focused on the advancement of novel genetic medicines with headquarters in Hayward, California. The proprietary platform, called DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitate sustained silencing of disease-causing genes following a single administration. The Company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy (OPMD), and Chronic Hepatitis B.

Investor Contact Information


Benitec Biopharma Inc.
3940 Trust Way
Hayward, CA 94545

Investor Relations

Irina Koffler
Managing Director, LifeSci Advisors
T: 646-970-4681

Transfer Agent

Computershare Investor Services
P.O. Box 505005
Louisville, KY 40233-5005
T: 781-575-3100